Evidence map›Paper›PMID 16078134›Full record

Trial reportPharmaceutical research2005

Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.

Christoffer W Tornøe, Rune V Overgaard, Henrik Agersø, Henrik A Nielsen, Henrik Madsen, E Niclas Jonsson

Abstract readClinical TrialMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Pharmaceutical research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Multi-scale digital twins for personalized medicine.Frontiers in digital health · 2026
    Review
  6. Article
  7. A tutorial on pharmacometric Markov models.CPT: pharmacometrics & systems pharmacology · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Beyond Deterministic Models in Drug Discovery and Development.Trends in pharmacological sciences · 2020
    Review
  12. Article
  13. Article
  14. Pharmacometrics models with hidden Markovian dynamics.Journal of pharmacokinetics and pharmacodynamics · 2018
    Article
  15. Article
  16. Article
  17. Stochastic nonlinear mixed effects: a metformin case study.Journal of pharmacokinetics and pharmacodynamics · 2016
    Article
  18. Article
  19. Modeling and simulation of count data.CPT: pharmacometrics & systems pharmacology · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christoffer W TornøeExperimental Medicine, Ferring Pharmaceuticals A/S, DK-2300, Copenhagen S, Denmark. christoffer.tornoe@ferring.com
Rune V Overgaard
Henrik Agersø
Henrik A Nielsen
Henrik Madsen
E Niclas Jonsson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe objective of the present analysis was to explore the use of stochastic differential equations (SDEs) in population pharmacokinetic/pharmacodynamic (PK/PD) modeling.

methodsThe intra-individual variability in nonlinear mixed-effects models based on SDEs is decomposed into two types of noise: a measurement and a system noise term. The measurement noise represents uncorrelated error due to, for example, assay error while the system noise accounts for structural misspecifications, approximations of the dynamical model, and true random physiological fluctuations. Since the system noise accounts for model misspecifications, the SDEs provide a diagnostic tool for model appropriateness. The focus of the article is on the implementation of the Extended Kalman Filter (EKF) in NONMEM for parameter estimation in SDE models.

resultsVarious applications of SDEs in population PK/PD modeling are illustrated through a systematic model development example using clinical PK data of the gonadotropin releasing hormone (GnRH) antagonist degarelix. The dynamic noise estimates were used to track variations in model parameters and systematically build an absorption model for subcutaneously administered degarelix.

conclusionsThe EKF-based algorithm was successfully implemented in NONMEM for parameter estimation in population PK/PD models described by systems of SDEs. The example indicated that it was possible to pinpoint structural model deficiencies, and that valuable information may be obtained by tracking unexplained variations in parameters.

Indexed as

AlgorithmsModels, StatisticalPharmacokineticsSoftwareStochastic ProcessesAntineoplastic AgentsDatabases, FactualDose-Response Relationship, DrugHalf-LifeHumansIntestinal AbsorptionLinear ModelsMaleNonlinear DynamicsOligopeptidesProstatic Neoplasmsacetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamideAntineoplastic AgentsOligopeptidesReceptors, LHRH

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.